Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on July 22, 2002

Circulation. 2002
Published online before print July 22, 2002, doi: 10.1161/01.CIR.0000025635.38200.75
A more recent version of this article appeared on August 13, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/7/814    most recent
01.CIR.0000025635.38200.75v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheng, J.
Right arrow Articles by Scheinman, M. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cheng, J.
Right arrow Articles by Scheinman, M. M.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs

Submitted on February 28, 2002
Revised on May 23, 2002
Accepted on May 24, 2002

Electrophysiological Response of the Right Atrium to Ibutilide During Typical Atrial Flutter

Jie Cheng MD, PhD, Kathryn Glatter MD, Yanfei Yang MD, Shulong Zhang MD, Randall Lee MD, and Melvin M. Scheinman MD*

From the Section of Cardiac Electrophysiology, University of California San Francisco, San Francisco, Calif. Dr Cheng is presently with Michigan State University, College of Human Medicine, East Lansing, Mich.

* To whom correspondence should be addressed. E-mail: scheinman{at}ep4.ucsf.edu.

Background—The efficacy of ibutilide in conversion of atrial fibrillation and flutter (AFL) has been demonstrated. However, its electrophysiological effects on human atria have not been fully studied.

Methods and Results—Twelve patients with typical AFL were studied. Electrograms were recorded from the anterolateral right atrium, His bundle position, and coronary sinus. During AFL, we measured the conduction time, CTi, through the isthmus between the tricuspid annulus and eustachian ridge and the conduction time, CTni, through the remainder of the right atrium. Resetting response curves and atrial effective refractory periods were determined with single extrastimuli delivered in the tricuspid annulus--eustachian ridge isthmus. After infusion of ibutilide (2 mg over 15 minutes), AFL cycle length (CL) increased from 260±30 to 295±39 ms (P<0.0003) because of an increase in either CTi, CTni, or both. Effective refractory periods increased from 149±16 to 208±26 ms (P<0.001). AFL CL variability increased, with a rightward shift of the resetting response curves and loss of full excitability. In 8 patients, AFL was terminated by atrial overdrive pacing after ibutilide at CLs equal to or longer than those that were not effective at baseline, which was caused by orthodromic block in the tricuspid annulus--eustachian ridge isthmus or was associated with development of transient rapid rhythms around newly formed sites of intra-atrial conduction block.

Conclusions—Ibutilide causes prolongation of AFL CL and increased CL variability by abolishment of a fully excitable gap. Ibutilide may facilitate pace termination of AFL by development of new short-lived reentry around functional blocks.


Key words: atrial flutter • electrophysiology • antiarrhythmic agents




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-C. Chou, S. Zhou, A. Y. Tan, H. Hayashi, M. Nihei, and P.-S. Chen
High-density mapping of pulmonary veins and left atrium during ibutilide administration in a canine model of sustained atrial fibrillation
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2704 - H2713.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. Mazza, M. S. Fera, I. Bisceglia, F. Bettiol, G. Pulignano, P. Tanzi, C. Gaudio, and E. Giovannini
Efficacy and safety of ibutilide vs. transoesophageal atrial pacing for the termination of type I atrial flutter
Europace, January 1, 2004; 6(4): 301 - 306.
[Abstract] [Full Text] [PDF]